Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Apo-D ELISA Kit (AC2412)
Cat.#: ASET-1001
Specifications
Description Human Apo-D ELISA Kit allows for the in vitro quantitative determination of human Apo-D concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.375 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.625-40 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1998 Human Vaspin ELISA Kit (AC3409) Quantitative inquiry ASET-1826 Human KIBRA ELISA Kit (AC3237) Quantitative inquiry ASET-2278 Human GAP43 ELISA Kit (AC3689) Quantitative inquiry ASET-1338 Human FOXO1A ELISA Kit (AC2749) Quantitative inquiry ASET-1761 Human MAPK ELISA Kit (AC3172) Quantitative inquiry ASET-2124 Human GDF11 ELISA Kit (AC3535) Quantitative inquiry ASET-1392 Human Semaphorin 3A ELISA Kit (AC2803) Quantitative inquiry ASET-1476 Mouse Amyloid Precursor Protein ELISA Kit (AC2887) Quantitative inquiry ASET-1321 Human Dopamine Transporter ELISA Kit (AC2732) Quantitative inquiry ASET-2499 Human Galanin ELISA Kit (AC3910) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket